{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T04:22:51Z","timestamp":1761970971128,"version":"build-2065373602"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2012,12,15]],"date-time":"2012-12-15T00:00:00Z","timestamp":1355529600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2013,5]]},"DOI":"10.1007\/s00520-012-1668-4","type":"journal-article","created":{"date-parts":[[2012,12,14]],"date-time":"2012-12-14T05:23:38Z","timestamp":1355462618000},"page":"1321-1327","source":"Crossref","is-referenced-by-count":9,"title":["Symptom to door interval in febrile neutropenia: perspective in India"],"prefix":"10.1007","volume":"21","author":[{"given":"Sapna","family":"Oberoi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amita","family":"Trehan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R. K.","family":"Marwaha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deepak","family":"Bansal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,12,15]]},"reference":[{"key":"1668_CR1","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1080\/08880010802106564","volume":"25","author":"S Bakhshi","year":"2008","unstructured":"Bakhshi S, Padmanjali KS, Arya LS (2008) Infections in childhood acute lymphoblastic leukemia: an analysis of 222 febrile neutropenic episodes. Pediatr Hematol Oncol 25:385\u2013392","journal-title":"Pediatr Hematol Oncol"},{"key":"1668_CR2","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1097\/MPH.0b013e31820ff632","volume":"33","author":"S Gupta","year":"2011","unstructured":"Gupta S, Bonilla M, Gamero M et al (2011) Microbiology and mortality of pediatric febrile neutropenia in El Salvador. J Pediatr Hematol Oncol 33:276\u2013280","journal-title":"J Pediatr Hematol Oncol"},{"key":"1668_CR3","doi-asserted-by":"crossref","first-page":"271","DOI":"10.3109\/08880019409141670","volume":"11","author":"NS Raje","year":"1994","unstructured":"Raje NS, Rao SR, Iyer RS et al (1994) Infection analysis in acute lymphoblastic leukemia: a report of 499 consecutive episodes in India. Pediatr Hematol Oncol 11:271\u2013280","journal-title":"Pediatr Hematol Oncol"},{"key":"1668_CR4","doi-asserted-by":"crossref","first-page":"2258","DOI":"10.1002\/cncr.21847","volume":"106","author":"NM Kuderer","year":"2006","unstructured":"Kuderer NM, Dale DC, Crawford J et al (2006) Mortality, morbidity, and cost associated with febrile neutropenia in adult cancer patients. Cancer 106:2258\u20132266","journal-title":"Cancer"},{"key":"1668_CR5","doi-asserted-by":"crossref","first-page":"809","DOI":"10.2165\/11592980-000000000-00000","volume":"30","author":"SL Michels","year":"2012","unstructured":"Michels SL, Barron RL, Reynolds MW et al (2012) Costs associated with febrile neutropenia in the US. PharmacoEconomics 30:809\u2013823","journal-title":"PharmacoEconomics"},{"issue":"9","key":"1668_CR6","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1097\/MPH.0b013e3181b1edc6","volume":"31","author":"H Hakim","year":"2009","unstructured":"Hakim H, Flynn PM, Knapp KM, Srivastava DK, Gaur AH (2009) Etiology and clinical course of febrile neutropenia in children with cancer. J Pediatr Hematol Oncol 31(9):623\u2013629","journal-title":"J Pediatr Hematol Oncol"},{"key":"1668_CR7","doi-asserted-by":"crossref","first-page":"e56","DOI":"10.1093\/cid\/cir073","volume":"52","author":"AG Freifeld","year":"2011","unstructured":"Freifeld AG, Bow EJ, Sepkowitz KA et al (2011) Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the Infectious Diseases Society of America. Clin Infect Dis 52:e56\u2013e93","journal-title":"Clin Infect Dis"},{"key":"1668_CR8","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1177\/1043454208319971","volume":"25","author":"AL Corey","year":"2008","unstructured":"Corey AL, Snyder S (2008) Antibiotics in 30 minutes or less for febrile neutropenic patients: a quality control measure in a new hospital. J Pediatr Oncol Nurs 25:208\u2013212","journal-title":"J Pediatr Oncol Nurs"},{"key":"1668_CR9","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s00277-007-0390-7","volume":"87","author":"J Zuckermann","year":"2008","unstructured":"Zuckermann J, Moreira LB, Stoll P et al (2008) Compliance with a critical pathway for the management of febrile neutropenia and impact on clinical outcomes. Ann Hematol 87:139\u2013145","journal-title":"Ann Hematol"},{"key":"1668_CR10","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1001\/archinte.162.6.682","volume":"162","author":"DS Battleman","year":"2002","unstructured":"Battleman DS, Callahan M, Thaler HT (2002) Rapid antibiotic delivery and appropriate antibiotic selection reduce length of hospital stay of patients with community-acquired pneumonia: link between quality of care and resource utilization. Arch Intern Med 162:682\u2013688","journal-title":"Arch Intern Med"},{"key":"1668_CR11","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1056\/NEJMoa010307","volume":"345","author":"E Rivers","year":"2001","unstructured":"Rivers E, Nguyen B, Havstad S et al (2001) Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 345:1368\u20131377","journal-title":"N Engl J Med"},{"key":"1668_CR12","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.ccm.2008.06.011","volume":"29","author":"SR Townsend","year":"2008","unstructured":"Townsend SR, Schorr C, Levy MM et al (2008) Reducing mortality in severe sepsis: the Surviving Sepsis Campaign. Clin Chest Med 29:721\u2013733, x","journal-title":"Clin Chest Med"},{"key":"1668_CR13","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1093\/qjmed\/hcr217","volume":"105","author":"SJ Sammut","year":"2012","unstructured":"Sammut SJ, Mazhar D (2012) Management of febrile neutropenia in an acute oncology service. QJM 105:327\u2013336","journal-title":"QJM"},{"key":"1668_CR14","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1002\/pbc.23418","volume":"59","author":"E Burry","year":"2011","unstructured":"Burry E, Punnett A, Mehta A et al (2011) Identification of educational and infrastructural barriers to prompt antibiotic delivery in febrile neutropenia: a quality improvement initiative. Pediatr Blood Cancer 59:431\u2013435. doi: 10.1002\/pbc.23418","journal-title":"Pediatr Blood Cancer"},{"key":"1668_CR15","first-page":"429","volume":"22","author":"MES Ben-Yakov","year":"2010","unstructured":"Ben-Yakov MES, Kiss A, J-Schull M (2010) CBC testing before physician assessment delays antibiotics in emergency febrile neutropenia patients. Emergencias 22:429\u2013434","journal-title":"Emergencias"},{"key":"1668_CR16","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1111\/j.1365-2354.2011.01264.x","volume":"20","author":"M Vliet van","year":"2011","unstructured":"van Vliet M, Potting CM, Sturm PD et al (2011) How prompt is prompt in daily practice? Earlier initiation of empirical antibacterial therapy for the febrile neutropenic patient. Eur J Cancer Care (Engl) 20:679\u2013685","journal-title":"Eur J Cancer Care (Engl)"},{"issue":"103","key":"1668_CR17","first-page":"e109","volume":"26","author":"VM Amado","year":"2011","unstructured":"Amado VM, Vilela GP, Queiroz A Jr et al (2011) Effect of a quality improvement intervention to decrease delays in antibiotic delivery in pediatric febrile neutropenia: a pilot study. J Crit Care 26(103):e109\u2013e112","journal-title":"J Crit Care"},{"key":"1668_CR18","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/BF02725598","volume":"70","author":"D Mishra","year":"2003","unstructured":"Mishra D, Singh HP (2003) Kuppuswamy's socioeconomic status scale\u2014a revision. Indian J Pediatr 70:273\u2013274","journal-title":"Indian J Pediatr"},{"key":"1668_CR19","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1097\/01.CCM.0000217961.75225.E9","volume":"34","author":"A Kumar","year":"2006","unstructured":"Kumar A, Roberts D, Wood KE et al (2006) Duration of hypotension prior to initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med 34:1589\u20131596","journal-title":"Crit Care Med"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-012-1668-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00520-012-1668-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-012-1668-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T02:04:22Z","timestamp":1559095462000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00520-012-1668-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,12,15]]},"references-count":19,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2013,5]]}},"alternative-id":["1668"],"URL":"https:\/\/doi.org\/10.1007\/s00520-012-1668-4","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"type":"print","value":"0941-4355"},{"type":"electronic","value":"1433-7339"}],"subject":[],"published":{"date-parts":[[2012,12,15]]}}}